Upchurch GR Jr. Review course in the essentials of vascular surgery for general and vascular surgeons. Postgraduate course. 95th annual clinical congress. ACS. Chicago Il. October 2009.
Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: A randomized controlled trial (decrease-IV). Ann Surg 2009; 249: 921-926.
GALA trial collaborative group. General anesthesia versus local anaesthesia for carotid surgery (GALA): A multicentre, randomized controlled trial. Lancet 2008; 372: 2132-2142.
Yadav JS. Carotid Stenting in high risk patients: Design and rationale of the SAPPHIRE trial. Cleve Clin J Med 2004; (Suppl 1): S45-S46.
Edwards NM, Fabian TC, Claridge JA, et al. Antithrombotic therapy and endovascular stents are effective treatment for blunt carotid injuries: Results from long term follow up. J Am Coll Surg 2007; 204: 1007-1003.
Huber TS, Ozaki CK, Flynn TC, et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg 2002; 36: 452-459.
Huber TS, Brown MP, Seeger JM, et al. Midterm outcome after the distal revascularization and interval ligation (DRIL) procedure. J Vasc Surg 2008; 48: 926-932.
Hoff WS, Hoey BA, Wainwright GA, et al. Early experience with retrievable inferior vena cava filters in high-risk trauma patients. J Am Coll Surg 2004; 199: 869-874.
Rosenthal D, Wellons ED, Levitt AB, et al. Role of prophylactic temporary inferior vena cava filters placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma. J Vasc Surg 2004; 40: 958-964.
Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: The PREPIC (prevention du risque d´embolie pulmonaire par interruption cave) randomized study. Circulation 2005; 112: 416-422.
Adam DJ, Beard JD, Cleveland T, et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicenter, randomized controlled trial. Lancet 2005; 366: 1925-1934.
Giles KA, Pomposelli FB, Hamdan AD, et al. Infrapopliteal angioplasty for critical limb ischaemia: Relation of transatlantic intersociety consensus class to outcome in 176 limbs. J Vasc Surg 2008; 48: 128-136.
Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. J Vasc Interv Radiol 2007; 18: 703-708.
Grant AG, White CJ, Collins TJ, et al. Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv 2008; 71: 108-111.
Das T, McNamara T, Gray B, et al. Cryoplasty therapy for limb salvage in patients with critical limb ischemia. J Endovasc Ther 2007; 14: 753-762.
Laird JR, Zeller T, Gray BH, et al. LACI investigators. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006; 13: 1-11.
Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON registry: Treating peripherals with silverhawk: Outcomes collection. J Endovasc Ther 2006; 13: 592-602.
Safian RD, Niazi K, Runyon JP, et al. OASIS investigators. Orbital atherectomy for infrapopliteal disease: Device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv 2009; 73: 406-412.
Hirsh AT, Hasjak ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary. J Am Coll Cardiol 2006; 47: 1239-1312.
Norgren L, Hiat WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33(suppl 1): S1-S75. Available at: Nhttp://www.google.com.mx/search?hl=es&source=hp&q=http%3A%2F%2Fwww.tasc-2-pad.org%2FClient%2FEN%2Findex.aspx%3FComposant%3DRubrique%26IDBase%3D561%26Methode%3DClientFDetail%26Ref%3DHome.&btnG=Buscar+con+Google&meta=&aq=o&oq=. Accessed July 28,2009.
Miyamoto K, Nishigami K, Nagaya N, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-2684.
Powel R, Simons M, Mendelsohn F, et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 2008; 118: 58-65.
Rajagopalan S, Olin J, Deitcher S, et al. Use of a constitutively active hypoxia-inducible factor -1B transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience. Circulation 2007; 115: 1234-1243.
Clouse WD, Rasmussen TE, Peck MA, et al. Current in theater management of wartime vascular injury: a report from operation Iraqi freedom. J Am Coll Surg 2007; 204: 625-632.
Krag JFW TJ, Baer DG, Fox CJ, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma 2008; 64: 13-16.
Woodward EB, Clouse WD, Eliason JE, et al. Penetrating femoropopliteal injury during modern warfare: Experience of the Balad vascular registry. J Vasc Surg 2008; 47: 1259-1264.
Quan RW, Gillespie DL, Stuart BS, et al. The effect of vein repair on the risk of venous thromboembolic events: A review of more than 100 traumatic military venous injuries. J Vasc Surg 2008; 47: 571-577.
Ly, TVT TG, Castillo RC, Bosse MJ, et al. Ability of lower extremity injury severity score to predict functional outcome after limb salvage. J Bone Joint Surg Am 2008; 90: 6-10.